From 1915 to 2017: continuing on the path of innovation and Discovery
Discovery is a Publication of the Patrick C. Walsh prostate cancer research fund that is bringing you advances in some of our most exciting treatments and research toward preventing and curing genitourinary cancers.

Read the latest edition

The Brady Urological Institute, which opened in 1915, was the first urology residency in the United States. From its inception, this Institute has been dedicated to the training of academic urologists. We have well-developed programs in all aspects of adult and pediatric urology including robotics, reconstructive surgery, urological oncology, male infertility and sexual dysfunction, urodynamics, female urology, endourology, laparoscopy, and stone disease.

The Brady has been a leader in the study of Urologic diseases for over 100 years. Emphasis is placed on finding the causes of diseases as well as developing new treatments to relieve the burden of illness on patients and their families.

The Brady is among the premier Urological Institutes in the world. The Johns Hopkins Hospital and The Brady have been ranked one of the top hospitals and Urology Departments in America by U.S. News & World Report.
MAKE AN APPOINTMENT

Eugene Fuller Triennial Prostate Award

Dr. Carter, Professor of Urology and Oncology, is an internationally recognized expert in the diagnosis and treatment of prostate cancer.

Dr. Carter trained in urological surgery at The New York Hospital-Cornell Medical Center and completed a fellowship in urological oncology at the Brady Urological Institute at Johns Hopkins. In 1989, he joined the Johns Hopkins Medicine faculty as an assistant professor of urology, was promoted to associate professor in 1993, and full professor of urology and oncology in 1998.

Dr. Carter’s career has been focused on promoting a balanced approach to prostate cancer diagnosis and treatment. Although trained as a surgeon, he has been a voice of reason emphasizing the public health concerns of over diagnosis and over treatment of prostate cancer. Dr. Carter’s research interests and academic involvement have been directed toward reducing the harms of prostate cancer screening by improving screening practices. He led the American Urological Association Guideline Panel for the Diagnosis of Prostate Cancer that developed the first urological guidelines for prostate cancer screening. His development of a program in 1995 at Johns Hopkins to reduce the unnecessary treatment of localized prostate cancer has led to the acceptance of active surveillance as a standard of care approach to the management of favorable risk disease.

For his outstanding contributions in the field of prostate cancer, specifically in the areas of PSA screening and surveillance, Dr. Carter has been recognized by the American Urological Association with the Urology Care Foundation Distinguished Scholar Alumnus, the Distinguished Contribution Award, the Eugene Fuller Triennial Prostate Award, and the Huggins Medal from the Society of Urologic Oncology.

How your gift helps the Brady Urological Institute
Philanthropic support is critical to our continued success in the diagnosis and care of patients and the research that drives new treatments, new therapies and new surgical techniques.
Make a gift